Izun Pharmaceuticals dedicates their work to harnessing the power of natural botanical ingredients. Just this week, Izun Pharmaceuticals received a patent (US Pat. No. 10,653,787) for a water-based cannabinoid and opioid composition. 

To help increase the cannabinoid’s solubility in water, it is bound to a plasma protein such as albumin. Many industries will benefit from enhancing the solubility of cannabinoids in water. For more information, check out Magic Number’s article on cannabinoid biosynthesis. 

Patent ‘787 is Izun Pharmaceuticals first issued patent in the sector of cannabis. To see the IP of many more companies for increasing the stability of cannabinoids, subscribe to Magic Number’s Cannabis Patent Forecast® and search the ‘Compositions - Stability’ tag.